Literature DB >> 8431526

Correlation between the prevalence of gastritis and gastric cancer in Japan.

A Fukao1, S Hisamichi, N Ohsato, N Fujino, N Endo, M Iha.   

Abstract

To verify the hypothesis that chronic atrophic gastritis (CAG) is a precancerous lesion for gastric cancer, we investigated the correlation between the prevalence rates for CAG determined by levels of serum pepsinogens (I and II) of randomly selected, healthy, blood donors and the mortality rates for gastric cancer among four prefectures (Akita, Iwate, Miyagi, and Okinawa) in Japan. The prevalence rates for CAG according to a criterion that the level of pepsinogen I is below 70 ng/ml and the pepsinogen I to pepsinogen II ratio is below 3.0, were the highest in Akita for both sexes (38.8 percent in males, 37.8 percent in females) and the lowest in Okinawa (13.9 percent in males, 12.3 percent in females), where mortality rates for gastric cancer are the highest and the lowest in Japan, respectively. The correlation between the prevalence rates for CAG and the standardized mortality ratios for gastric cancer among these four prefectures was statistically significant in males (r = 0.97, P = 0.03), but less significant in females (r = 0.92, P = 0.08). These data strongly support the hypothesis that CAG is a precancerous lesion. The limitations of our cross-sectional study and the advantages of measuring the levels of serum pepsinogens in epidemiologic studies and in mass-screening programs for gastric cancer are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431526     DOI: 10.1007/bf00051709

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  Chronic gastritis: a clinico-pathological classification.

Authors:  P Correa
Journal:  Am J Gastroenterol       Date:  1988-05       Impact factor: 10.864

2.  Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence.

Authors:  I M Samloff; W M Liebman
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

3.  Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence.

Authors:  I M Samloff
Journal:  Gastroenterology       Date:  1971-08       Impact factor: 22.682

4.  Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.

Authors:  I M Samloff; K Varis; T Ihamaki; M Siurala; J I Rotter
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

5.  Precancerous changes in the stomach.

Authors:  T Kawachi; M Kurisu; N Numanyu; K Sasajima; T Sano
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

6.  Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.

Authors:  M Ichinose; K Miki; C Furihata; T Kageyama; R Hayashi; H Niwa; H Oka; T Matsushima; K Takahashi
Journal:  Clin Chim Acta       Date:  1982-12-09       Impact factor: 3.786

7.  Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.

Authors:  B D Westerveld; G Pals; C B Lamers; J Defize; J C Pronk; R R Frants; E C Ooms; J Kreuning; P J Kostense; A W Eriksson
Journal:  Cancer       Date:  1987-03-01       Impact factor: 6.860

8.  The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects.

Authors:  K Miki; M Ichinose; N Kawamura; M Matsushima; H B Ahmad; M Kimura; J Sano; T Tashiro; N Kakei; H Oka
Journal:  Jpn J Cancer Res       Date:  1989-02
  8 in total
  11 in total

1.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations.

Authors:  F Kitahara; K Kobayashi; T Sato; Y Kojima; T Araki; M A Fujino
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

2.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

3.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

4.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

5.  Serum pepsinogen and Helicobacter pylori infection--a Japanese population study.

Authors:  K Toyoda; N Furusyo; T Ihara; H Ikezaki; Y Urita; J Hayashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-22       Impact factor: 3.267

6.  Expression of growth hormone and its receptor in chronic atrophic gastritis and its clinical significance.

Authors:  Jian-Min Si; Qian Cao; Min Gao
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Serum pepsinogen in screening for gastric cancer.

Authors:  A Kodoi; M Yoshihara; K Sumii; K Haruma; G Kajiyama
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

8.  Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study.

Authors:  A Fukao; S Komatsu; Y Tsubono; S Hisamichi; H Ohori; T Kizawa; N Ohsato; N Fujino; N Endo; M Iha
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

Review 9.  Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

Authors:  Kazumasa Miki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

10.  Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.

Authors:  Y Hattori; H Tashiro; T Kawamoto; Y Kodama
Journal:  Jpn J Cancer Res       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.